KDventures CSO John Öhd transitions to senior advisor role
KDventures announced today that John Öhd is transitioning from chief scientific officer to senior advisor. Öhd will focus his operational efforts on portfolio company Modus Therapeutics. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to